Consolidated and Combined Statements of Changes in Equity - USD ($) $ in Millions	Total	Common stock	Treasury stock	Additional paid-in capital	Retained earnings	Net parent investment	Accumulated other comprehensive income (loss) – net	Equity attributable to noncontrolling interests
Equity, beginning balance (in shares) at Dec. 31, 2021		0
Equity, beginning balance at Dec. 31, 2021	$ 16,676	$ 0	$ 0	$ 0	$ 0	$ 17,692	$ (1,037)	$ 21
Treasury stock, beginning balance (in shares) at Dec. 31, 2021			0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income attributable to GE HealthCare	1,916					1,916
Other comprehensive income (loss) attributable to GE HealthCare	(841)						(841)
Transfers (to) from GE	(8,373)					(8,373)
Changes in equity attributable to noncontrolling interests	(16)							(16)
Equity, ending balance (in shares) at Dec. 31, 2022		0
Equity, ending balance at Dec. 31, 2022	9,362	$ 0	$ 0	0	0	11,235	(1,878)	5
Treasury stock, ending balance (in shares) at Dec. 31, 2022			0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net transfers from GE, including Spin-Off-related adjustments	(2,849)					(4,851)	2,000	2
Issuance of common stock in connection with the Spin-Off and reclassification of net parent investment (in shares)		454,000,000
Issuance of common stock in connection with the Spin-Off and reclassification of net parent investment	0	$ 5		6,379		(6,384)
Issuance of shares under equity awards, net of shares withheld for taxes and other (in shares)		1,000,000
Net income attributable to GE HealthCare	1,568				1,568
Dividends declared	(55)				(55)
Other comprehensive income (loss) attributable to GE HealthCare	(813)						(813)
Changes in equity attributable to noncontrolling interests	5							5
Share-based compensation	114			114
Changes in equity due to redemption value adjustments on redeemable noncontrolling interests	$ (187)				(187)
Equity, ending balance (in shares) at Dec. 31, 2023	455,342,290	455,000,000
Equity, ending balance at Dec. 31, 2023	$ 7,145	$ 5	$ 0	6,493	1,326	0	(691)	12
Treasury stock, ending balance (in shares) at Dec. 31, 2023	0		0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of shares under equity awards, net of shares withheld for taxes and other (in shares)		2,000,000
Issuance of shares under equity awards, net of shares withheld for taxes and other	$ (60)		$ (25)	(35)
Net income attributable to GE HealthCare	1,993				1,993
Dividends declared	(58)				(58)
Other comprehensive income (loss) attributable to GE HealthCare	(688)						(688)
Changes in equity attributable to noncontrolling interests	7							7
Share-based compensation	$ 125			125
Equity, ending balance (in shares) at Dec. 31, 2024	457,246,971	457,000,000
Equity, ending balance at Dec. 31, 2024	$ 8,464	$ 5	$ (25)	$ 6,583	$ 3,262	$ 0	$ (1,379)	$ 18
Treasury stock, ending balance (in shares) at Dec. 31, 2024	291,053		0